Publicaties

Stemkens R, Mouhdad C, Franssen EJF, Touw D, Alffenaar JW, Te Brake LHM, Sturkenboom MGG, Aarnoutse RE. Ten-year results of an international external quality control programme for measurement of anti-tuberculosis drug concentrations. J Antimicrob Chemother. 2024 Jun 3;79(6):1346-1352. doi: 10.1093/jac/dkae105. PMID: 38581098; PMCID: PMC11144482.

Jager NGL, Van Ewijk-Beneken Kolmer E, Aarnoutse R, Te Brake LHM. Influence of ultrafiltration conditions on the measurement of unbound drug concentrations: flucloxacillin as an example. J Antimicrob Chemother. 2024 Apr 3:dkae092. doi: 10.1093/jac/dkae092. Epub ahead of print. PMID: 38569058.

van Rossum HH, van Schrojenstein Lantman M, Severens M, Vermeer HJ, Verboeket-van de Venne WPHG, Oosterhuis W, de Jonge N. Quality control in the Netherlands; todays practices and starting points for guidance and future research. Clin Chem Lab Med. 2024 Apr 26;62(11):2177-2184. doi: 10.1515/cclm-2024-0316. PMID: 38661089.

van Rossum HH, Holdenrieder S, Ballieux BEPB, Badrick TC, Yun YM, Zhang C, Patel D, Thelen M, Song J, Wojtalewicz N, Unsworth N, Vesper HW, Cui W, Ramanathan LV, Sturgeon C, Meng QH. Investigating the Current Harmonization Status of Tumor Markers Using Global External Quality Assessment Programs: A Feasibility Study. Clin Chem. 2024 Feb 22:hvae005. doi: 10.1093/clinchem/hvae005. Epub ahead of print. PMID: 38385453.

Thelen MHM, van Schrojenstein Lantman M. When bias becomes part of imprecision: how to use analytical performance specifications to determine acceptability of lot-lot variation and other sources of possibly unacceptable bias. Clin Chem Lab Med. 2024 Feb 8. doi: 10.1515/cclm-2023-1303. Epub ahead of print. PMID: 38353157.

Boonstra MB, Koelewijn R, Brienen EAT, Tassche-Borggreve K, Kortbeek LM, Mank TG, Mulder B, Stelma F, van Lieshout L, van Hellemond JJ. Identification of gaps in the performance of routine microscopy for the diagnosis of parasitic infections revealed by the Dutch laboratory quality assessment scheme. Clin Microbiol Infect. 2024 Jun;30(6):833-835. doi: 10.1016/j.cmi.2024.02.018. Epub 2024 Feb 23. PMID: 38402953.

van Schrojenstein Lantman M, Grobben R, van Herwaarden AE, van Berkel M, Schaap J, Thelen M. To rule-in, or not to falsely rule-out, that is the question: evaluation of hs-cTnT EQA performance in light of the ESC-2020 guideline. Clin Chem Lab Med. 2024 Feb 7. doi: 10.1515/cclm-2023-1226. Epub ahead of print. PMID: 38353154.

Meško Brguljan P, Thelen MHM, Bernabeu-Andreu FA, Kroupis C, Boursier G, Vukasović I, Barrett E, Brugnoni D, Lohmander M, Šprongl L, Vodnik T, Ghiţă I, Vanstapel F, Vaubourdolle M, Huisman W. EFLM Working Group Accreditation and ISO/CEN standards on dealing with ISO 15189 demands for retention of documents and examination objects. Adv Lab Med. 2024 Jan 30;5(2):103-108. doi: 10.1515/almed-2023-0053. PMID: 38939196; PMCID: PMC11206180.

Çubukçu HC, Vanstapel F, Thelen M, van Schrojenstein Lantman M, Bernabeu-Andreu FA, Meško Brguljan P, Milinkovic N, Linko S, Panteghini M, Boursier G. APS calculator: a data-driven tool for setting outcome-based analytical performance specifications for measurement uncertainty using specific clinical requirements and population data. Clin Chem Lab Med. 2023 Nov 17;62(4):597-607. doi: 10.1515/cclm-2023-0740. PMID: 37978287.

Heron M, Schreurs MWJ, Haagen IA, China B, Faria AP, Vanhanen AR, Thelen M, Weykamp CW. Allergy: Evaluation of 16 years (2007-2022) results of the shared external quality assessment program in Belgium, Finland, Portugal and The Netherlands. Clin Chem Lab Med. 2023 Nov 28. doi: 10.1515/cclm-2023-0862. Epub ahead of print. PMID: 38008748.